| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/18/2000 | CA2087960C Endogenously sweetened transgenic plant products |
| 01/18/2000 | CA2050336C Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
| 01/18/2000 | CA2006587C Membrane proteins and peptides of haemophilus influenzae type b |
| 01/14/2000 | CA2237704A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 01/13/2000 | WO2000001831A2 Proteases fused with variants of streptomyces subtilisin inhibitor |
| 01/13/2000 | WO2000001827A2 Polyketides, their preparation, and materials for use therein |
| 01/13/2000 | WO2000001817A2 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | WO1999057241A3 Myelin basic protein peptides and uses thereof |
| 01/13/2000 | WO1999046286A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 01/13/2000 | CA2332573A1 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | CA2332491A1 Polyketides, their preparation, and materials for use therein |
| 01/13/2000 | CA2332177A1 Proteases fused with variants of streptomyces subtilisin inhibitor |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0658120B1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241212A Compound and methods for immunotherapy and diagnosis of tuberculosis |
| 01/11/2000 | US6013526 Modified protein for gene transfer and process for producing the same |
| 01/11/2000 | US6013503 Mammailian enzymatic fusion protein associated with the urogenital system; for screening of modulators of enzyme activity |
| 01/11/2000 | US6013480 Antagonists of interleukin-15 |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/06/2000 | WO2000000618A2 Polyketides and their synthesis |
| 01/06/2000 | WO2000000500A2 Polyketides and their synthesis |
| 01/06/2000 | CA2335523A1 Polyketides and their synthesis |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0968291A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/05/2000 | EP0968289A1 Icam-6 materials and methods |
| 01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
| 01/05/2000 | EP0652758B1 Diphtheria toxin vaccines |
| 01/04/2000 | US6010884 Recombinant binding proteins and peptides |
| 01/04/2000 | US6010883 Recombinant fusion proteins |
| 01/04/2000 | US6010844 Methods of preparing and recovering proteins |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067294A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 12/29/1999 | WO1999067293A1 Peptide composition as immunogen for the treatment of allergy |
| 12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
| 12/29/1999 | EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 12/29/1999 | CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | CA2329755A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 12/28/1999 | US6008336 Compacted nucleic acids and their delivery to cells |
| 12/28/1999 | US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent |
| 12/28/1999 | US6008023 Producing a fusion protein by transforming a thioredoxin reductase-deficient escherichia with a nucleotide molecule encoding an antibody or fragment; culturing and expressing the antibody; isolating antibody from the cytoplasm |
| 12/28/1999 | CA1340863C Domain-modified constant region antibodies |
| 12/28/1999 | CA1340861C Cysteine-depleted muteins of biologically active proteins |
| 12/23/1999 | WO1999066054A2 Erythropoietin analog-human serum albumin fusion protein |
| 12/23/1999 | WO1999066053A1 Expression vector for use in a one-step purification protocol |
| 12/23/1999 | WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | WO1999065940A1 Anti-angiogenic proteins and methods of use thereof |
| 12/23/1999 | WO1999065936A2 Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 12/23/1999 | WO1999051741A3 Lyst protein complexes and lyst interacting proteins |
| 12/23/1999 | CA2333602A1 Expression vector for use in a one-step purification protocol |
| 12/23/1999 | CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | CA2331332A1 Anti-angiogenic proteins and methods of use thereof |
| 12/23/1999 | CA2330527A1 Erythropoietin analog-human serum albumin fusion |
| 12/22/1999 | EP0965638A2 G-CSF analog compositions and methods |
| 12/22/1999 | EP0965595A1 Protein complex |
| 12/22/1999 | EP0964699A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF |
| 12/22/1999 | EP0964691A1 Use of conantokins |
| 12/22/1999 | EP0876160B1 Ligand directed enzyme prodrug therapy |
| 12/22/1999 | EP0785992A4 Conditional transformation of genetically engineered cells |
| 12/22/1999 | CN1238990A Pigment marked protein composite and its preparing method |
| 12/21/1999 | US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis |
| 12/21/1999 | US6004941 Introducing nucleic acid encoding fusion protein which activates transcription and comprises a polypeptide that binds to tetracycline operator |
| 12/21/1999 | US6004811 Isolated cytotoxic t-cell which expresses a membrane-bound chimeric receptor which binds target cell and signals to destroy bound target cell; targets infected, cancerous, tumor or autoimmune-generated cells |
| 12/21/1999 | US6004746 Interaction trap systems for detecting protein interactions |
| 12/21/1999 | US6004557 Variants of human papillomavirus antigens |
| 12/21/1999 | CA2072891C Pseudomonas exotoxin fusion proteins having carboxyl alterations with increased cytotoxicity |
| 12/16/1999 | WO1999064603A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
| 12/16/1999 | WO1999064595A1 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME |
| 12/16/1999 | WO1999064586A2 Phagocytic assay method |
| 12/16/1999 | WO1999064574A1 Method to prepare c-terminal modified peptides |
| 12/16/1999 | WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 12/16/1999 | WO1999064455A1 Peptides having nuclear transport activity |
| 12/16/1999 | WO1999064067A2 Vaccine |
| 12/16/1999 | WO1999055899A9 Methods for transducing fusion molecules |
| 12/16/1999 | WO1999054467A9 Sh2 domain-containing peptides |
| 12/16/1999 | WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto |
| 12/16/1999 | WO1998024902A8 Adaptor protein frs2 and related products and methods |
| 12/16/1999 | CA2332993A1 Phagocytic assay method |
| 12/16/1999 | CA2330548A1 Peptides having nuclear transport activity |
| 12/16/1999 | CA2330238A1 Vaccine |
| 12/16/1999 | CA2329942A1 Therapeutic and diagnostic domain 1 .beta.2gpi polypeptides and methods of using same |
| 12/15/1999 | EP0963432A1 Kuz, a novel family of metalloproteases |
| 12/14/1999 | US6001973 Antagonists of interleukin-15 |
| 12/14/1999 | US6001649 Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production |
| 12/14/1999 | CA2135642C Tat-derived transport polypeptides |
| 12/14/1999 | CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms |
| 12/14/1999 | CA2089161C Separation of proteins and dyes |
| 12/14/1999 | CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3 |
| 12/09/1999 | WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 12/09/1999 | WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 12/09/1999 | CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 12/08/1999 | EP0961829A1 Fusion proteins for intracellular and intercellular transport and their uses |
| 12/08/1999 | EP0961828A1 Ciita-interacting proteins and methods of use therefor |